RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.6 BRL | -0.18% |
|
+7.60% | -6.12% |
| 05-08 | Transcript : Raia Drogasil S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| 05-07 | Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 39.26B 7.69B 10.47B | Sales 2025 * | 44.96B 8.81B 11.99B | Capitalization | 47.34B 9.28B 12.63B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.38B 271M 369M | Net income 2025 * | 1.82B 357M 487M | EV / Sales 2024 * | 1.39 x |
| Net Debt 2024 * | 7.39B 1.45B 1.97B | Net Debt 2025 * | 7.51B 1.47B 2B | EV / Sales 2025 * | 1.22 x |
| P/E ratio 2024 * |
33.7
x | P/E ratio 2025 * |
24.5
x | Employees | 57,708 |
| Yield 2024 * |
0.98% | Yield 2025 * |
1.7% | Free-Float | 74.06% |
More Fundamentals
* Assessed data
More news
Latest transcript on Raia Drogasil S.A.
More press releases
| 1 day | -0.18% | ||
| 1 week | +7.60% | ||
| Current month | +7.90% | ||
| 1 month | +8.45% | ||
| 3 months | +10.84% | ||
| 6 months | +0.91% | ||
| Current year | -6.12% |
1 week
26.56
27.72
1 month
24.4527.72
Current year
24.3029.87
1 year
24.3030.15
3 years
17.1430.15
5 years
12.4830.15
10 years
3.4530.15
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 13-06-30 | |
| Director of Finance/CFO | 60 | 13-04-28 | |
| Investor Relations Contact | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 11-11-23 | |
| Director/Board Member | 72 | 13-04-28 | |
| Director/Board Member | 46 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 17 M€ | -8.09% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 14 M€ | -1.21% | ||
| 1.19% | 0 M€ | -6.18% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 27.6 | -0.18% | 4,226,300 |
| 24-05-16 | 27.65 | +2.18% | 6,200,900 |
| 24-05-15 | 27.06 | -0.04% | 4,775,900 |
| 24-05-14 | 27.07 | +1.96% | 17,366,100 |
| 24-05-13 | 26.55 | +3.51% | 10,065,200 |
Delayed Quote Sao Paulo, May 17, 2024 at 04:07 pm
More quotes
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
2024-08-05
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
27.6
BRL
Average target price
30.71
BRL
Spread / Average Target
+11.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.12% | 9.26B | |
| +31.94% | 1.34B | |
| -7.54% | 367M | |
| +2.64% | 271M | |
| +12.22% | 231M | |
| -39.42% | 93.41M | |
| -9.17% | 87.11M | |
| +19.44% | 59.57M |
- Stock Market
- Equities
- RADL3 Stock
